tiprankstipranks
Trending News
More News >

Rhythm Biosciences Issues New Unquoted Securities

Story Highlights

An update from Rhythm Biosciences Ltd. ( (AU:RHY) ) is now available.

Rhythm Biosciences Ltd. announced the issuance of 401,716 unquoted securities, specifically options expiring on March 31, 2026, with an exercise price of $0.20. This issuance is part of previously announced transactions and is not intended to be quoted on the ASX. The move reflects the company’s ongoing strategic financial maneuvers to support its operations and growth within the biotechnology sector, potentially impacting its market positioning and stakeholder interests.

More about Rhythm Biosciences Ltd.

Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of medical diagnostics. The company is primarily engaged in creating innovative solutions for early detection of diseases, particularly in the area of cancer diagnostics, aiming to improve patient outcomes and healthcare efficiency.

YTD Price Performance: -32.22%

Average Trading Volume: 268,872

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$17.68M

See more data about RHY stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App